Showing results (491-500 of 867) with videos related to

Sort By:
Pageof 87
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 29, 2024
Do Contemporary Cancer Survivors Experience Better Quality of Life? Evaluating a Decade of SEER Medicare Health Outcomes Survey DataBenjamin T Allaire, Marc L Horvath, Lisa M Lines, et al.
Journal of Geriatric Oncology|December 19, 2017
Healthcare experience among older cancer survivors: Analysis of the SEER-CAHPS datasetMichael T Halpern, Matthew P Urato, Lisa M Lines, et al.
Journal of Psychiatric Research|September 11, 2007
Is bigger better for depression trials?Kenneth S Liu, Duane B Snavely, William A Ball, et al.
The American Journal of Pathology|February 15, 2012
S100P-binding protein, S100PBP, mediates adhesion through regulation of cathepsin Z in pancreatic cancer cellsKate E Lines, Claude Chelala, Branko Dmitrovic, et al.
Neurology|November 30, 2000
Within-patient consistency of response of rizatriptan for treating migraineC G Dahlöf, R B Lipton, K A McCarroll, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 3, 2013
A randomized controlled trial evaluating the erythropoiesis stimulating agent sparing potential of a vitamin E-bonded polysulfone dialysis membraneSimon W Lines, Angela M Carter, Emma J Dunn, et al.
Cephalalgia : an International Journal of Headache|August 10, 2014
Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxisAlmira Chabi, Ying Zhang, Saheeda Jackson, et al.
Endocrine Reviews|November 29, 2020
Multiple Endocrine Neoplasia Type 1: Latest InsightsMaria Luisa Brandi, Sunita K Agarwal, Nancy D Perrier, et al.
Journal of Bacteriology|March 21, 2006
Polyamines are essential for the formation of plague biofilmChandra N Patel, Brian W Wortham, J Louise Lines, et al.
Schizophrenia Research|March 26, 2013
Randomized crossover study of the histamine H3 inverse agonist MK-0249 for the treatment of cognitive impairment in patients with schizophreniaMichael F Egan, Xin Zhao, Regina Gottwald, et al.
Pageof 87